| Application no. and date | 20703606.2 (espacenet) (Federated) (European Patent Register), 20200107 | | Patent/reg. no. and date | DK/EP 3908282, 20250702 | | Publication date | 20211117 | | Priority no. and date | US 201962789177 P, 20190107 | | EP pub. no. and date |
EP 3908282 20211117 | | Effective date | | | Applicant/owner | Ideaya Biosciences, Inc., 5000 Shoreline Court, Suite 300
South San Francisco, CA 94080, US | | Applicant ref. no. | PV2123DKEP | | Inventor | KNOX, John, 2526 Woodland Place
Emerald Hills, CA 94062, US,
LACKNER, Mark, 746 26th Avenue
San Mateo, CA 94403, US,
MOUNIR, Zineb, 1030 Fassler Avenue
Pacifica, CA 94044, US,
O'BRIEN, Carol, 276 Mendocino Street
Brisbane, CA 94005, US | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) | | Title | BEHANDLING AF KRÆFT MED GNAQ- ELLER GNA11-GENETISKE MUTATIONER MED PROTEINKINASE C-HÆMMERE | | Int. application no. | US2020012542 | | Int. publication no. | WO2020146355 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
